Korea Investment Partners

Founded 1986

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 107
Average round size
info
The average size of a deal this fund participated in
$16M
Portfolio companies 83
Rounds per year 2.37
Lead investments 8
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.07
Exits 12
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Information Technology
  • Mobile
  • Software
Summary

Korea Investment Partners appeared to be the VC, which was created in 1986. The company was established in Asia in South Korea. The main office of represented VC is situated in the Seoul.

The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Mobile, Advertising. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Ansun BioPharma, Huuuge Games, Pavilion Data Systems. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.

Deals in the range of 10 - 50 millions dollars are the general things for fund. This Korea Investment Partners works on 21 percentage points less the average amount of lead investments comparing to the other organizations. The fund is generally included in 7-12 deals every year. The top amount of exits for fund were in 2019. The top activity for fund was in 2018. The real fund results show that this VC is 14 percentage points more often commits exit comparing to other companies. The typical startup value when the investment from Korea Investment Partners is 100-500 millions dollars.

The overall number of key employees were 32.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Korea Investment Partners, startups are often financed by LVP, Kleiner Perkins, Heartcore Capital. The meaningful sponsors for the fund in investment in the same round are Mirae Asset Venture Investment, Kleiner Perkins, DSC Investment. In the next rounds fund is usually obtained by Upscale, UOB Venture, Tera Ventures.

Read more

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Tribe Accelerator

Automotive
Blockchain
Information Technology
InsurTech
Logistics
Supply Chain Management
Sustainability
70M14 Apr 2021

Geneos Therapeutics

Biotechnology
Health Care
Pharmaceutical
Therapeutics
Early Stage Venture
12M03 Mar 2021 United States, Whitemarsh Township

Early Stage Venture
10M04 Dec 2020

Early Stage Venture
21M27 Oct 2020

Early Stage Venture
12M16 Oct 2020

Late Stage Venture
62M22 Sep 2020

Early Stage Venture
10M15 Sep 2020

Seed
10M24 Jun 2020

Early Stage Venture
15M01 May 2020
News
Revenue-based financing startup Jenfi raises $6.3M to focus on high-growth Southeast Asian companies
– Jenfi, a Singapore-based startup, raised $6.3m in Series A funding. – The round was led by Monk’s Hill Ventures and joined by Korea Investment Partners, Golden Equator Capital, 8VC, ICU Ventures and Taurus Ventures. – The company previously raised $25m in debt financing from San Francisco-based Arc Labs. – Jenfi works primarily with “digital-native” companies, including SaaS providers and e-commerce sellers. – It claims that the average Jenfi customer experienced compounded sales growth of about 26... Read more
S-Alpha Therapeutics, Inc., Digital Therapeutics Start-up Raises $8.7 Million in Series A Funding
– S-Alpha Therapeutics announced the completion of its Series A financing. – The company raised a total of $8.7M USD (10 Billion KRW) in financing round. – In Series A funding, all existing investors participated in this investment, and Korea Investment Partners, Stonebridge Ventures, Devsisters Ventures/KDB Capital, and Timewise Investment participated as new investors. Read more

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Korea Investment Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: